Options for treatment of hepatitis C in HIV-infected persons
Open Access
- 31 December 2006
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 44, S40-S43
- https://doi.org/10.1016/j.jhep.2005.11.011
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Pilot Study of Low‐Dose Interleukin‐2, Pegylated Interferon–α2b, and Ribavirin for the Treatment of Hepatitis C Virus Infection in Patients with HIV InfectionThe Journal of Infectious Diseases, 2005
- Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patientsGastroenterology, 2005
- Pegylated Interferon Alfa-2b vs Standard Interferon Alfa-2b, Plus Ribavirin, for Chronic Hepatitis C in HIV-Infected PatientsA Randomized Controlled TrialJAMA, 2004
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected PatientsNew England Journal of Medicine, 2004
- Peginterferon Alfa-2a plus Ribavirin versus Interferon Alfa-2a plus Ribavirin for Chronic Hepatitis C in HIV-Coinfected PersonsNew England Journal of Medicine, 2004
- Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis CAnnals of Internal Medicine, 2004
- Monitoring of viral levels during therapy of hepatitis CHepatology, 2002
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002